NATIONAL HEREDITARY BREAST CANCER HELPLINE Financials
- Company number
- 07877025CopyCopy
- Registered office
- Unit 71 Storforth Lane Trading Estate Storforth Lane, Hasland, Chesterfield, Derbyshire S41 0QZ
- Incorporated
- 09/12/2011
Company snapshot
- Status
- Active
- Employees
- 11 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
-61.47%vs 20242024: £100.97K
Total Assets
-49.09%vs 20242024: £191.16K
Cash in Bank
-53.10%vs 20242024: £4.68K
Total Liabilities
-53.02%vs 20242024: £90.18K
Employees
-3vs 20242024: 14
In 2025, NATIONAL HEREDITARY BREAST CANCER HELPLINE reported net assets of £38.91K. The same filing shows total assets of £97.31K, cash in bank of £2.19K and total liabilities of £42.37K. Reported headcount was 11 in 2025. Total Assets fell from £191.16K in 2024 to £97.31K in 2025 (-49.09%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-61.47%from £100.97K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures NATIONAL HEREDITARY BREAST CANCER HELPLINE filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
-62%vs 2023-38.4% a year compound (CAGR)
Cash in Bank
-84.2%vs 2023-60.2% a year compound (CAGR)
Total Assets
-47.8%vs 2023-27.8% a year compound (CAGR)
Total Liabilities
-49.6%vs 2023-29% a year compound (CAGR)
Employees
-15.4%vs 2023-2Biggest decrease
Cash in Bank-84.2%
£13.85K in 2023 to £2.19K in 2025
Every indicator Okredo holds for NATIONAL HEREDITARY BREAST CANCER HELPLINE fell between 2023 and 2025. The steepest fall came in cash in bank, pointing to a tighter cash position, with net assets, total assets, total liabilities and employee numbers falling alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from NATIONAL HEREDITARY BREAST CANCER HELPLINE's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 39.98%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 43.54%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 5.18%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 2.25%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for NATIONAL HEREDITARY BREAST CANCER HELPLINE by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 102.99K | 120.47K | 102.43K | 100.97K | 38.91K |
| Total Assets£ | 234.46K | 195.77K | 186.52K | 191.16K | 97.31K |
| Cash in Bank£ | 59.06K | 21.50K | 13.85K | 4.68K | 2.19K |
| Total Liabilities£ | 131.46K | 75.29K | 84.09K | 90.18K | 42.37K |
| Employees | 13 | 16 | 13 | 14 | 11 |
NATIONAL HEREDITARY BREAST CANCER HELPLINE financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for NATIONAL HEREDITARY BREAST CANCER HELPLINE covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
NATIONAL HEREDITARY BREAST CANCER HELPLINE reported net assets of £38.91K for 2025. That compares with £100.97K in 2024, a change of -61.47%.
NATIONAL HEREDITARY BREAST CANCER HELPLINE reported total assets of £97.31K for 2025. That compares with £191.16K in 2024, a change of -49.09%.
NATIONAL HEREDITARY BREAST CANCER HELPLINE reported cash in bank of £2.19K for 2025. That compares with £4.68K in 2024, a change of -53.10%.
NATIONAL HEREDITARY BREAST CANCER HELPLINE reported 11 employees in 2025, compared with 14 in 2024.
Between 2023 and 2025, NATIONAL HEREDITARY BREAST CANCER HELPLINE's net assets fell by 62%, cash in bank fell by 84.2%, total assets fell by 47.8% and total liabilities fell by 49.6%. Net assets contracted at 38.4% a year across the two years to 2025, from £102.43K to £38.91K. Reported headcount went from 13 in 2023 to 11 in 2025 (-2).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.